SEC Filing Details

Our enduring purpose: to fundamentally improve the lives of patients with serious diseases in ways never before possible.

SEC Filing Details

Document Details

Filing Date
Apr 22, 2020
Document Date
Apr 22, 2020
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.